Freezing or ultrasound for early prostate cancer
Part of Cancer, Kidney & urinary clinical trials.
This trial is testing whether freezing (cryotherapy) or using high-frequency ultrasound (HIFU) to destroy only the cancer spots in the prostate is safe and effective for men with early-stage prostate cancer. It's a less invasive option that targets just the tumor, not the whole prostate.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have prostate cancer that is low or intermediate risk (Gleason score 6 or 7, or Grade Group 1, 2, or 3).
- The cancer is just on one side of your prostate and can be seen on an MRI scan (up to 3 spots).
- You must be at least 18 years old and your doctor thinks you have at least 5 more years to live.
- You should be able to do most of your daily activities without help (ECOG 0 or 1).
- You cannot have had any prior treatment for prostate cancer (like surgery, radiation, or hormone therapy).
- You must be willing to sign a consent form and follow the study procedures.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether a high-intensity focused ultrasound treatment can help people with localized prostate cancer while still avoiding traditional full-dose treatment for some patients. It may be an option for certain intermediate-risk cases where the cancer is confined to the prostate.
This trial tests using MRI and ultrasound together to guide freezing (cryoablation) treatment for prostate cancer. It may help target the tumor more precisely while avoiding areas that could cause side effects.
This trial tests whether freezing only the cancer area in the prostate (focal cryotherapy) can control intermediate-risk prostate cancer. It aims to limit treatment to one tumor focus while closely checking results with targeted and follow-up testing.
This trial studies a focused ultrasound treatment called HIFU for prostate cancer that appears limited to the early stages. It aims to treat cancer within the prostate while avoiding treatment spread to lymph nodes or distant organs.
This study collects data on men with early, low-risk prostate cancer who choose to have a targeted ultrasound treatment called HIFU (High-Intensity Focused Ultrasound). It looks at how well this treatment works and how men recover.
This trial tests combining a focused ultrasound treatment (high-intensity focused ultrasound) with a new type of hormone therapy for men with advanced prostate cancer that has spread. The goal is to see if this combination can help control the cancer better than hormone therapy alone.
Hear when a new Stage I Prostate Cancer AJCC v8 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.